Covid-19 and diabetes in primary care – How do hematological parameters present in this cohort?

References

• [cited 2021 Mar 15]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
   Google Scholar
• [cited 2021 Mar 15]. Available from: https://www.worldometers.info/coronavirus
   Google Scholar
• Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068–1077.
   PubMed Web of Science ®Google Scholar
• Aktas G. A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection. Exp Biomed Res. 2020;3(4):293–311.
   Google Scholar
• Mirzaei F, Khodadadi I, Vafaei SA, et al. Importance of hyperglycemia in COVID-19 intensive-care patients: mechanism and treatment strategy. Prim Care Diabetes. 2021;S1751-9918(21)00002–4.
   Google Scholar
• Farahani F, Mirzaei F, Khodadadi I, et al. Importance of hyperglycemia in preoperative, intraoperative and postoperative periods in COVID-19 patients. Int J Surg. 2020;83:1–2.
   PubMed Web of Science ®Google Scholar
• Dergaa I, Varma A, Tabben M, et al. Organising football matches with spectators during the COVID-19 pandemic: what can we learn from the Amir Cup Football Final of Qatar 2020? A call for action. Biol Sport. 2021;38(4):677–681.
   Web of Science ®Google Scholar
• Trabelsi K, Ammar A, Masmoudi L, et al. Globally altered sleep patterns and physical activity levels by confinement in 5056 individuals: ECLB COVID-19 international online survey. Biol Sport. 2021;38(4):495–506.
   Web of Science ®Google Scholar
• Varma A, Dergaa I, Ashkanani M, et al. Analysis of Qatar’s successful public health policy in dealing with the Covid-19 pandemic. Int J Med Rev Case Rep. 2021;5(2):6–11.
   Google Scholar
• Varma A, Abubaker M, Dergaa I. Extensive Saliva based COVID-19 testing–the way forward to curtail the global pandemic? J Med Res. 2020;6(6):309–310.
   Google Scholar
• Varma A, Dergaa I, Zidan M, et al. Covid-19:“Drive thru swabbing hubs”–safe and effective testing for travellers. J Med Res. 2020;6(6):311–312.
   Google Scholar
• Mohammed AR. Should all patients having planned procedures or surgeries be tested for COVID-19. Am J Surg Clin Case Rep. 2020;2(2):1–3.
   Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Kumar Nathella P, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13–24.
   PubMed Web of Science ®Google Scholar
• Xu M, Liu PP, Li H. Innate immune signaling and its role in metabolic and cardiovascular diseases. Physiol Rev. 2019;99(1):893–948.
   PubMed Web of Science ®Google Scholar
• Barron E, Bakhai C, Kar P, et al., Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020:8(10):813–822.
   PubMed Web of Science ®Google Scholar
• [cited 2021 Mar 15]. https://www.aa.com.tr/en/africa/who-18-of-covid-19-deaths-in-africa-tied-to-diabetes/2041918
   Google Scholar
• Forbes A, Murrells T, Mulnier H, et al. Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6(6):476–486.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S61–S70.
   PubMedGoogle Scholar
• Tao Z, Xu J, Chen W, et al. Anemia is associated with severe illness in COVID‐19: a retrospective cohort study. J Med Virol. 2021;93(3):1478–1488.
   PubMed Web of Science ®Google Scholar
• Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;1450(1):15–31.
   PubMed Web of Science ®Google Scholar
• Capoğlu I, Ünüvar N, Bektaş Y, et al. The effects of high haematocrit levels on glucose metabolism disorders. J Int Med Res. 2002;30(4):433–437.
   PubMed Web of Science ®Google Scholar
• Barbieri M, Ragno E, Benvenuti E, et al. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia. 2001;44(10):1232–1237.
   PubMed Web of Science ®Google Scholar
• Li G, Deng Q, Feng J, et al. Clinical characteristics of diabetic patients with COVID-19. J Diabetes Res. 2020;1652403. DOI: 10.1155/2020/1652403.
   PubMedGoogle Scholar
• Liang JJ, Liu J, Chen Y, et al. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus. Diabetes Res Clin Pract. 2020;167:108351. .
   PubMed Web of Science ®Google Scholar
• Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, et al., Hematological findings and complications of COVID‐19. Am J Hematol. 2020:95(7):834–847.
   PubMed Web of Science ®Google Scholar
• Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133(11):1261–1267.
   PubMed Web of Science ®Google Scholar
• Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818.
   PubMed Web of Science ®Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768.
   PubMed Web of Science ®Google Scholar
• Henry BM, De Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028.
   PubMed Web of Science ®Google Scholar
• Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):E131–E134.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148.
   PubMed Web of Science ®Google Scholar
• Qu R, Ling Y, Zhang YH, et al., Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020:92(9):1533–1541.
   PubMed Web of Science ®Google Scholar
• Güçlü E, Kocayiğit H, Okan HD, et al. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras (1992). 2020;66(8):1122–1127.
   PubMed Web of Science ®Google Scholar
• Foy BH, Carlson JCT, Reinertsen E, et al. Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA Network Open. 2020;3(9):e2022058.
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Duman TT, et al. Mean platelet volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Med J. 2018;7(3):650–653.
   Web of Science ®Google Scholar
• Crespo‐Leiro MG, Metra M, Lund LH, et al. Advanced heart failure: a position statement of the heart failure association of the European society of cardiology. Eur J Heart Fail. 2018;20(11):1505–1535.
   PubMed Web of Science ®Google Scholar
• Dagistan Y, Dagistan E, Gezici A, et al. Could red cell distribution width and mean platelet volume be a predictor for lumbar disc hernias? Ideggyogy Sz. 2016;69(11–12):411–414.
   PubMedGoogle Scholar
• Sit M, Aktas G, Ozer B, et al. Mean platelet volume: an overlooked herald of malignant thyroid nodules. Acta Clin Croat. 2019;58(3):417–420.
   PubMed Web of Science ®Google Scholar
• Atak BM, Duman TT, Aktas G, et al. Platelet distribution width is associated with type 2 diabetes mellitus and diabetic nephropathy and neuropathy. National J Health Sci. 2018;3(3):95–98.
   Google Scholar
• Aktas G, Alcelik A, Tekce BK, et al. Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Prz Gastroenterol. 2014;9(3):160–163.
   PubMedGoogle Scholar
• Aktas G, Sit M, Dikbas O, et al. Could red cell distribution width be a marker in Hashimoto’s thyroiditis? Exp Clin Endocrinol Diabetes. 2014;122(10):572–574.
   PubMed Web of Science ®Google Scholar
• Aktas G, Sit M, Karagoz I, et al. Could red cell distribution width be a marker of thyroid cancer? J Coll Physicians Surg Pak. 2017;27(9):556–558.
   PubMed Web of Science ®Google Scholar
• Bilgin S, Aktas G, Zahid Kocak M, et al. Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men. Aging Male. 2019;1–5. DOI:10.1080/13685538.2019.1632283
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Patel M, Charlett A, et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill. 2020;25(32):2001483.
   PubMedGoogle Scholar